Amgen: Biotech Giant's Path to Growth and Recovery
Amgen has navigated headwinds to chart a path toward renewed growth. This analysis breaks down the catalysts, risks, ...
There are countless ways to make additional income. Find the best methods that suit your skills and schedule to enhance your earnings.
17,258 articlesAmgen has navigated headwinds to chart a path toward renewed growth. This analysis breaks down the catalysts, risks, ...
A prominent fund has taken a sizable stake in Kirby Corporation, with eyes on a bold earnings target of $6.33 per sha...
This week’s CPI data could tilt policy expectations: a hotter print may bolster a hawkish stance from the new Fed lea...
U.S. equities fell after inflation data exceeded expectations and AI disruption fears grew. Tech-led losses and risin...
Kick off the holiday with a focused investing reading list. This Friday Juneteenth reads roundup blends market insigh...
Tesla’s foray into robotics and AI promises upside, but it also introduces new risks for shareholders. This guide bre...
Two Vanguard growth ETFs sit at the crossroads of technology exposure and broad market reach. This guide breaks down ...
This deep dive breaks down AKA Brands' 2025 Q4 results. Learn what the numbers mean for the business, where growth ca...
Public romance buzz can spill into your wallet. This article breaks down practical money moves you can make when cele...
This week, newmont stock dropped over 10% as traders weighed shifting gold prices and fresh company data. The move hi...
Major research firm reaffirmed its price target on Terawulf as the company inks a long-term lease with Anthropic and ...
Liberty Formula One stock trades around $83 after a strong Q4. Jim Cramer flags the pullback as a terrific buying opp...